Skip to content
10-K

Annual Report

NPS PHARMACEUTICALS INC

0001136261-14-000082

← back to feed
Filed
Feb 18, 2014 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2013 · Feb 11, 2014 102.8M sh
Operating Cash Flow FY 2013 · Dec 31, 2013 −$24.32M
Operating Cash Flow FY 2013 · Dec 31, 2012 −$60.99M
Operating Cash Flow FY 2013 · Dec 31, 2011 −$56.66M
Stock Issued FY 2013 · May 31, 2013 6.9M sh
Long Term Debt FY 2013 · Dec 31, 2012 $169.57M
Short Term Debt FY 2013 · Dec 31, 2012 $6.28M
Current Liabilities FY 2013 · Dec 31, 2012 $29.57M
Total Liabilities FY 2013 · Dec 31, 2012 $205.75M
Current Assets FY 2013 · Dec 31, 2012 $137.05M
Total Assets FY 2013 · Dec 31, 2012 $151.11M
Eps Diluted FY 2013 · Dec 31, 2012 −$0.14
Eps Diluted FY 2013 · Sep 30, 2012 −$0.04
Eps Diluted FY 2013 · Jun 30, 2012 $0.08
Eps Diluted FY 2013 · Mar 31, 2012 −$0.12
Eps Diluted FY 2013 · Dec 31, 2011 −$0.45
Eps Basic FY 2013 · Dec 31, 2012 −$0.14
Eps Basic FY 2013 · Sep 30, 2012 −$0.04
Eps Basic FY 2013 · Jun 30, 2012 $0.08
Eps Basic FY 2013 · Mar 31, 2012 −$0.12
Eps Basic FY 2013 · Dec 31, 2011 −$0.45
Operating Income FY 2013 · Dec 31, 2012 −$8.02M
Operating Income FY 2013 · Sep 30, 2012 $733K
Operating Income FY 2013 · Jun 30, 2012 $11.21M
Operating Income FY 2013 · Mar 31, 2012 −$5.05M
Operating Income FY 2013 · Dec 31, 2011 $545K
Revenue FY 2013 · Dec 31, 2012 $27.18M
Revenue FY 2013 · Sep 30, 2012 $27.02M
Revenue FY 2013 · Jun 30, 2012 $53.52M
Revenue FY 2013 · Mar 31, 2012 $22.92M
Revenue FY 2013 · Dec 31, 2011 $101.65M
Shares Diluted FY 2013 · Dec 31, 2011 81.28M sh
Sga Expense FY 2013 · Dec 31, 2011 $24.23M
Rd Expense FY 2013 · Dec 31, 2011 $73.83M
Net Income FY 2013 · Dec 31, 2011 −$36.27M
Cost Of Revenue FY 2013 · Dec 31, 2011 $0
Cash And Equivalents FY 2013 · Dec 31, 2010 $77.17M
Stockholders Equity FY 2013 · Dec 31, 2010 −$155.28M